Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Bioorg Med Chem ; 22(15): 3887-90, 2014 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-25002232

RESUMEN

Sixteen triterpenoids (1-16), previously isolated from the aerial parts of the African medicinal plant Momordica balsamina or obtained by derivatization, were evaluated for their activity against liver stages of Plasmodium berghei, measuring the luminescence intensity in Huh-7 cells infected with a firefly luciferase-expressing P. berghei line, PbGFP-Luccon. Toxicity of compounds (1-16) was assessed on the same cell line through the fluorescence measurement of cell confluency. The highest activity was displayed by a derivative bearing two acetyl residues, karavoate B (7), which led to a dose-dependent decrease in the P. berghei infection rate, exhibiting a very significant activity at the lowest concentration employed (1 µM) and no toxicity towards the Huh-7 cells. It is noteworthy that, in previous studies, this compound was found to be a strong inhibitor of blood-stages of Plasmodium falciparum, thus displaying a dual-stage antimalarial activity.


Asunto(s)
Antimaláricos/química , Momordica/química , Triterpenos/química , Antimaláricos/aislamiento & purificación , Antimaláricos/farmacología , Línea Celular , Supervivencia Celular/efectos de los fármacos , Humanos , Momordica/metabolismo , Componentes Aéreos de las Plantas/química , Componentes Aéreos de las Plantas/metabolismo , Plantas Medicinales/química , Plantas Medicinales/metabolismo , Plasmodium falciparum/efectos de los fármacos , Triterpenos/aislamiento & purificación , Triterpenos/farmacología
2.
J Chem Inf Model ; 46(1): 365-79, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16426071

RESUMEN

In the absence of an experimentally solved structure, a homology model of a protein target can be used instead for virtual screening of drug candidates by docking and scoring. This approach poses a number of questions regarding the choice of the template to use in constructing the model, the accuracy of the screening results, and the importance of allowing for protein flexibility. The present study addresses such questions with compound screening calculations for multiple homology models of five drug targets. A central result is that docking to homology models frequently yields enrichments of known ligands as good as that obtained by docking to a crystal structure of the actual target protein. Interestingly, however, standard measures of the similarity of the template used to build the homology model to the targeted protein show little correlation with the effectiveness of the screening calculations, and docking to the template itself often is as successful as docking to the corresponding homology model. Treating key side chains as mobile produces a modest improvement in the results. The reasons for these sometimes unexpected results, and their implications for future methodologic development, are discussed.


Asunto(s)
Simulación por Computador , Evaluación Preclínica de Medicamentos/métodos , Modelos Moleculares , Quinasa 2 Dependiente de la Ciclina/metabolismo , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/metabolismo , Factor Xa/metabolismo , Ligandos , Docilidad , Unión Proteica , Conformación Proteica , Programas Informáticos , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA